Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Irritable Bowl Syndrome Linked to Chili Pepper Pain Receptor

By Labmedica staff writers
Posted on 18 Jun 2008
Scientists have discovered that people with irritable bowl syndrome (IBS) have higher than usual levels of nerve fibers expressing the transient receptor potential vanilloid 1 (TRPV1), responsible for causing a burning sensation when people eat chili peppers. More...
TRPV1 receptors are also known as capsaicin receptors.

A study, which was published in the June 11, 2008, issue of the journal Gut, suggests that doctors will be able to treat the pain suffered by people with IBS by targeting and blocking the pain receptor. People with severe pain from IBS are currently treated with opiates, which can have serious side effects. Painkillers such as paracetamol and ibuprofen tend to offer little relief. New painkillers to target TRPV1 are currently being developed by pharmaceutic companies and the new findings suggest that such drugs could tackle some of the symptoms of IBS.

Biopsies were studied of colon tissue taken from 23 patients with IBS and from 22 controls, recruited from the gastroenterology clinics and the endoscopy department at Imperial College Healthcare National Health Service (NHS) Trust (London, UK). An estimated one in five UK adults have irritable bowel syndrome (IBS), a painful condition that is poorly understood. Symptoms of IBS include abdominal pain, bloating, and bowel problems such as constipation or diarrhea.
The investigators believe their findings may explain why some people's IBS symptoms worsen after eating spicy food. They also suggest that the presence of more nerve fibers expressing the TRPV1 pain receptors might mean that people with IBS are more susceptible to pain. TRPV1 receptors are also known as capsaicin receptors.


Related Links:
Imperial College Healthcare National Health Service Trust

Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.